High-flow nasal cannula and extubation success in the premature infant: a comparison of two modalities

@article{Miller2010HighflowNC,
  title={High-flow nasal cannula and extubation success in the premature infant: a comparison of two modalities},
  author={Susan Mary Miller and Sue Ann Dowd},
  journal={Journal of Perinatology},
  year={2010},
  volume={30},
  pages={805-808}
}
Objective:To compare the effectiveness of Fisher and Paykel (FP) and Vapotherm (VT) high-flow nasal cannula (HFNC) in preventing reintubation either within 72 h or <7 days after extubation of premature infants. The primary outcome was the rate of extubation failure defined as reintubation within 72 h. Secondary outcomes included reintubation after ⩽7 days.Study Design:This was a prospective, randomized pilot study comparing the extubation success of 40 infants born between 26 and 29 weeks of… CONTINUE READING

Tables and Topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.
SHOWING 1-10 OF 26 CITATIONS

Nasal high flow treatment in preterm infants

  • Maternal Health, Neonatology and Perinatology
  • 2017
VIEW 2 EXCERPTS
CITES RESULTS & BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 18 REFERENCES

Clinical Projects Manager, Fisher & Paykel Healthcare. Personal communication by e-mail

R. Cornell
  • 2009
VIEW 2 EXCERPTS

Personal communication by phone and e-mail

Hines W. Director, North America, Vapotherm
  • 2009

High flow therapy and humidification: a summary of mechanisms of action, technology and research

T. Miller
  • Vapotherm Inc. Documents: Stevensville,
  • 2008